The clarification came from Union Health Secretary Rajesh Bhushan when he was asked for a response about Poonawalla's tweet highlighting issues in coronavirus vaccine production and distribution in India

The vaccines will have a ceiling price of US$3 per dose, thanks to investments made by partners such as the Coalition for Epidemic Preparedness Innovations (CEPI) and the Bill & Melinda Gates Foundation

Coronavirus vaccine: In August, the SII entered into a partnership with Gavi (Global Alliance for Vaccines and Immunisation), and Bill & Melinda Gates Foundation to produce 100 million (10 crore) doses for India and LMICs

Speaking on the occasion, Union health minister Harsh Vardhan said that the first COVID-19 vaccine in India will most likely be available by the first quarter of 2021

The government is aiming to implement all the four labour codes in one go by December this year and complete the final stretch of labour sector reforms; With total cases standing at 32.4 million or 0.4 per cent of the world's population, every 250th person on the Earth is now infected with coronavirus; A day after Prime Minister Narendra Modi, in his address at the UN General Assembly, assured the world that India's vaccine production and delivery capacity will be used to help humanity in the COVID-19 crisis, world's largest vaccine maker Serum Institute of India (SII) Chief Executive Officer (CEO) Adar Poonawalla said SII also shares and applauds his vision. Watch this and more on News Blast.Also Read: SBI announces special benefits on home, auto, gold, personal loans

COVID-19 pandemic: One in every 250 people on Earth now infectedWith total cases standing at 32.4 million or 0.4 per cent of the world's population, every 250th person on the Earth is now infected with coronavirus. As of September 2020, the world's population stood at 7.8 billion, according to the estimates by the United Nations.The total number of deaths now stand at 983,000.Serum Institute shares, applauds PM Modi's vision: Adar Poonawalla on India's vaccine offer to worldA day after Pr...

The government is going to assess efficacy data of all concerned companies (working on COVID-19 vaccines) before inking a purchase contract with them and will buy vaccines at least for essential workers

Flipkart claims that it will offer the 'biggest offers on smartphones' including mobile protection for just Re 1 among other offers

One can stop receiving messages, calls and status updates from certain people by blocking them

Padukone accepted that she had sent those messages to her then-manager Karishma Prakash from a WhatsApp group but refused consumption or supply of any narcotics substance to anyone else. The actor used words like - maal, hash, weed - in her chat

Adar Poonawalla had earlier expressed concerns around production and distribution plans of the coronavirus vaccine. He asked if the Centre had Rs 80,000 crore available with it over next one year to distribute vaccine to Indians

Adar Poonawalla, CEO of the Serum Institute of India (SII), on Saturday expressed his concerns around production and distribution of coronavirus vaccine in the country

Bill Gates says India did some \"incredible things\" in terms of using digital infrastructure to transfer money to poor people; says the year 2020 has been an eye-opening year for him as he got time to do \"much more\"

Adar Poonawalla is the CEO of his family-owned company Serum Institute of India, which is the world's largest manufacturer of vaccines by volume. Poonawalla, who is in the spotlight in the global vaccine race for coronavirus, has promised to manufacture 400 million doses per month after the approval of the coronavirus vaccine. He has become the biggest hope for the global community during the pandemic. Serum Institute is currently conducting phase 3 clinical trials for the Oxford University-AstraZeneca vaccine. Here is all you need to know about the man himself and how he might prove to be our best bet during the pandemic. Watch the video for more.Also Read: Serum Institute to conduct clinical trials for Novavax COVID-19 vaccine

In recent weeks, Pfizer has said it should know by the end of October whether the vaccine, developed together with Germany's BioNTech SE, is safe and effective

Adar Poonawalla-helmed Serum Institute had partnered with Novavax in August for the production of its coronavirus vaccine. The US drug developer plans to manufacture 2 billion doses annually

Coronavirus vaccine trials: While China has four vaccine candidates in third or final stages of clinical trials, there are at least two companies from the United States and one from UK and Germany, which are planning to rollout vaccine before December, if everything goes as per the plan

COVID-19 to become seasonal? Herd immunity will decide frequency of outbreak, claims studyScientists have predicted that coronavirus will become a seasonal virus in countries with temperate climates only when herd humanity is attained. Until then, public health measures must be followed to curb the spread of the virus, a review published in Frontiers highlighted. Dr Hassan Zaraket of the American University of Beirut in Lebanon, added, \"COVID-19 is here to stay and it will continue to cause...

In August, Novavax signed a deal with Serum Institute, the world's largest producer of vaccines, to produce a minimum of one billion doses of its vaccine candidate, when approved, for low- and middle-income countries and India

COVID-19 vaccine candidates being developed by Cadila Healthcare and Bharat Biotech have completed the phase one of the study while Pune-based Serum Institute of India (SII) will begin with Phase 3 clinical trial after getting regulatory nod, says ICMR chief